Pharmacy: Links

Controlled Substance Information

&
Buprenorphine - Guidelines and Clinical Assistance
&
Buprenorphine - NM Guidelines
&
Buprenorphine Information
&
Code of Federal Regulations
&
Controlled Substance List
&
DEA Controlled Substance Registration
&
DEA Diversion Control
&
DEA Drug Disposal Information
&
Drug Enforcement Administration
&
Internal Pharmacy Theft
&
Methadone - Guidelines and Clinical Assistance
&
Permissible Changes to Schedule II Prescriptions
&
Pharmacist Manual
&
Practitioner's Manual
&
Purchaser Statements for Pseudoephedrine
&
Required DEA Training for Pseudoephedrine/Ephedrine Sales
&
Reverse Distributors

Adverse Drug Events / Medication Errors

&
Adverse Drug Event Form
&
American Society of Health-System Pharmacists Guidelines for Preventing Medication Errors
&
How to Report an Adverse Drug Event to the FDA
&
Institute for Safe Medication Practices (ISMP)
&
ISMP Medication Safety Self Assessment for Community/Ambulatory Pharmacy
&
ISMP Medication Safety Self Assessment for Hospitals
&
Preventing Medication Errors
&
To Err Is Human: Building a Safer Health System (2000)

General

&
AwareRx - Prescription Drug Safety
&
FDA Drug Shortages
&
New Mexico Monitored Treatment Program
&
Useful Web Sites
&
USP Compounding Standards

New Mexico Board of Pharmacy News

The New Mexico Board of Pharmacy uses the National Association of Boards of Pharmacy (NABP) to publish its quarterly newsletter. NABP posts the newsletter of all participating states. To go to NABP’s newsletter page, click on the link below.

&
New Mexico Board of Pharmacy Newsletter

To view, subscribe or unsubscribe to the NMBOP newsletter, please go to: https://nabp.pharmacy/boards-of-pharmacy/New-Mexico

The Food and Drug Administration, Center for Drug Evaluation and Research, Division of Drug Information offers a Drug Information Email Listserv. To subscribe, click: https://public.govdelivery.com/accounts/USFDA/subscriber/new?topic_id=USFDA_19

New Mexico PMP Gateway Integration

The New Mexico Board of Pharmacy (NM BOP) is integrating the Prescription Monitoring Program (PMP) system into eligible healthcare software systems across the state. The goal is to increase PMP utilization for both prescribers of controlled substances and pharmacists (“providers”) by providing seamless access to a patient’s queried PMP report.

The NM BOP currently contracts with Bamboo Health (formerly Appriss) for integration services, which provides a proprietary solution called PMP Gateway to integrate PMP data within a provider’s workflow. Healthcare entities in New Mexico that employ providers who are legally authorized to prescribe, administer or dispense controlled substance prescriptions are eligible to apply for this integration.

The NM BOP in collaboration with the New Mexico Department of Health (NM DOH), through federal grant funds, purchased a one (1) year subscription to the PMP Gateway for healthcare entities that successfully integrate before August 31, 2022. The one (1) year paid subscription for a healthcare entity begins the date PMP Gateway integration is approved by the New Mexico Board of Pharmacy (on or before 8/30/2022).

This the third year that the NM BOP has secured funding for Gateway Integration. Please note that the availability of funding after this subscription period is not guaranteed. Should the funding end after the one (1) year paid subscription, the Licensee has the option to renew the Agreement and would be responsible for all associated fees to continue the service.

Click here to learn more about the PMP Gateway and how to start the integration process.  If the hyperlink does not work, copy and paste the following web address into your internet browser – https://info.apprisshealth.com/nmgatewayintegrationrequest

Pharmacist Prescriptive Authority


Skip to content